EP Patent

EP0664117A1 — Liposomenlösungen

Assigned to F Hoffmann La Roche AG · Expires 1995-07-26 · 31y expired

What this patent protects

Die Erfindung betrifft wässrige Liposomenlösungen, die einen β-Lactamasehemmer und, gegebenenfalls, ein β-Lactamantibiotikum enthalten.

USPTO Abstract

Die Erfindung betrifft wässrige Liposomenlösungen, die einen β-Lactamasehemmer und, gegebenenfalls, ein β-Lactamantibiotikum enthalten.

Drugs covered by this patent

Patent Metadata

Patent number: EP0664117A1
Jurisdiction: EP
Classification: —
Expires: 1995-07-26
Drug substance claim: No
Drug product claim: No
Assignee: F Hoffmann La Roche AG
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.